Invention Grant
US08454956B2 Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies
有权
用抗IL-20抗体治疗类风湿性关节炎和骨质疏松症的方法
- Patent Title: Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies
- Patent Title (中): 用抗IL-20抗体治疗类风湿性关节炎和骨质疏松症的方法
-
Application No.: US12869224Application Date: 2010-08-26
-
Publication No.: US08454956B2Publication Date: 2013-06-04
- Inventor: Ming-Shi Chang
- Applicant: Ming-Shi Chang
- Applicant Address: TW Tainan
- Assignee: National Cheng Kung University
- Current Assignee: National Cheng Kung University
- Current Assignee Address: TW Tainan
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The invention features methods and compositions for preventing or treating rheumatoid arthritis and osteoporosis by administering an antagonist of IL-20. The IL-20 antagonist may be an anti-IL-20 antibody, such as mAB 7E, that is capable of binding human IL-20 and blocking IL-20 interaction with its receptors.
Public/Granted literature
- US20110064731A1 Use of IL-20 Antagonists for Treating Rheumatoid Arthritis and Osteoporosis Public/Granted day:2011-03-17
Information query
